Literature DB >> 18982161

The cytokine network in asthma and chronic obstructive pulmonary disease.

Peter J Barnes1.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are very common inflammatory diseases of the airways. They both cause airway narrowing and are increasing in incidence throughout the world, imposing enormous burdens on health care. Cytokines play a key role in orchestrating the chronic inflammation and structural changes of the respiratory tract in both asthma and COPD and have become important targets for the development of new therapeutic strategies in these diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982161      PMCID: PMC2575722          DOI: 10.1172/JCI36130

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  126 in total

1.  Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease.

Authors:  Adam Barczyk; Władysław Pierzchała; Onn M Kon; Borja Cosio; Ian M Adcock; Peter J Barnes
Journal:  J Allergy Clin Immunol       Date:  2006-04-03       Impact factor: 10.793

Review 2.  Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease.

Authors:  Louise E Donnelly; Peter J Barnes
Journal:  Trends Pharmacol Sci       Date:  2006-08-30       Impact factor: 14.819

Review 3.  Neuro-immune interaction in allergic asthma: role of neurotrophins.

Authors:  C Nassenstein; J Kutschker; D Tumes; A Braun
Journal:  Biochem Soc Trans       Date:  2006-08       Impact factor: 5.407

Review 4.  Phosphodiesterase inhibitors in airways disease.

Authors:  Kian Fan Chung
Journal:  Eur J Pharmacol       Date:  2006-02-02       Impact factor: 4.432

5.  Role of deficient type III interferon-lambda production in asthma exacerbations.

Authors:  Marco Contoli; Simon D Message; Vasile Laza-Stanca; Michael R Edwards; Peter A B Wark; Nathan W Bartlett; Tatiana Kebadze; Patrick Mallia; Luminita A Stanciu; Hayley L Parker; Louise Slater; Anita Lewis-Antes; Onn M Kon; Stephen T Holgate; Donna E Davies; Sergei V Kotenko; Alberto Papi; Sebastian L Johnston
Journal:  Nat Med       Date:  2006-08-13       Impact factor: 53.440

Review 6.  How corticosteroids control inflammation: Quintiles Prize Lecture 2005.

Authors:  Peter J Barnes
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

Review 7.  Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.

Authors:  Laurent Reber; Carla A Da Silva; Nelly Frossard
Journal:  Eur J Pharmacol       Date:  2006-02-17       Impact factor: 4.432

8.  IkappaB kinase-2-independent and -dependent inflammation in airway disease models: relevance of IKK-2 inhibition to the clinic.

Authors:  Mark A Birrell; Sissie Wong; Elizabeth L Hardaker; Matthew C Catley; Kerryn McCluskie; Michael Collins; Saleem Haj-Yahia; Maria G Belvisi
Journal:  Mol Pharmacol       Date:  2006-03-03       Impact factor: 4.436

9.  Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma.

Authors:  Bryce N Feltis; Dharshini Wignarajah; Ling Zheng; Chris Ward; David Reid; Richard Harding; E Haydn Walters
Journal:  Am J Respir Crit Care Med       Date:  2006-03-09       Impact factor: 21.405

10.  T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription.

Authors:  Takashi Usui; Jan C Preiss; Yuka Kanno; Zheng Ju Yao; Jay H Bream; John J O'Shea; Warren Strober
Journal:  J Exp Med       Date:  2006-03-06       Impact factor: 14.307

View more
  301 in total

1.  PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model.

Authors:  R Datta; A S Naura; M Zerfaoui; Y Errami; M Oumouna; H Kim; J Ju; V P Ronchi; A L Haas; A H Boulares
Journal:  Allergy       Date:  2011-01-28       Impact factor: 13.146

2.  The -308 G/A polymorphism in TNF-α gene is associated with asthma risk: an update by meta-analysis.

Authors:  Yonggang Zhang; Jie Zhang; Can Tian; Yuling Xiao; Chao He; Xiaobo Li; Amrit Bogati; Jin Huang; Hong Fan
Journal:  J Clin Immunol       Date:  2010-11-17       Impact factor: 8.317

Review 3.  Does airway smooth muscle express an inflammatory phenotype in asthma?

Authors:  Gautam Damera; Reynold A Panettieri
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

4.  Regulatory T cells and regulation of allergic airway disease.

Authors:  Helen Martin; Christian Taube
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

5.  Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways.

Authors:  David F Choy; Barmak Modrek; Alexander R Abbas; Sarah Kummerfeld; Hilary F Clark; Lawren C Wu; Grazyna Fedorowicz; Zora Modrusan; John V Fahy; Prescott G Woodruff; Joseph R Arron
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

6.  MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD.

Authors:  Alan C-Y Hsu; Kamal Dua; Malcolm R Starkey; Tatt-Jhong Haw; Prema M Nair; Kristy Nichol; Nathan Zammit; Shane T Grey; Katherine J Baines; Paul S Foster; Philip M Hansbro; Peter A Wark
Journal:  JCI Insight       Date:  2017-04-06

7.  ATP-binding cassette transporter 1 attenuates ovalbumin-induced neutrophilic airway inflammation.

Authors:  Cuilian Dai; Xianglan Yao; Boris Vaisman; Todd Brenner; Katharine S Meyer; Meixia Gao; Karen J Keeran; Gayle Z Nugent; Xuan Qu; Zu-Xi Yu; Pradeep K Dagur; J Philip McCoy; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

8.  Characterization of Transient Receptor Potential Vanilloid-1 (TRPV1) Variant Activation by Coal Fly Ash Particles and Associations with Altered Transient Receptor Potential Ankyrin-1 (TRPA1) Expression and Asthma.

Authors:  Cassandra E Deering-Rice; Chris Stockmann; Erin G Romero; Zhenyu Lu; Darien Shapiro; Bryan L Stone; Bernhard Fassl; Flory Nkoy; Derek A Uchida; Robert M Ward; John M Veranth; Christopher A Reilly
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

Review 9.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

10.  microRNA-149-5p mediates the PM2.5-induced inflammatory response by targeting TAB2 via MAPK and NF-κB signaling pathways in vivo and in vitro.

Authors:  Qiuyue Li; Siling Li; Chunjie Xu; Jing Zhao; Lin Hou; Fuyang Jiang; Zhonghui Zhu; Yan Wang; Lin Tian
Journal:  Cell Biol Toxicol       Date:  2021-07-31       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.